The Effect of Acceptance and Commitment Therapy on prostate cancer

Developing of Acceptance and Commitment Therapy (ACT) protocol based on psychological problems in people with prostate cancer and its effectiveness on health-related quality of life and psychological distress of them.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200209046424N1

Enrollment

Registered

2020-03-14

Start date

2020-01-01

Completion date

Unknown

Last updated

2020-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer. Malignant neoplasm of prostate

Interventions

Intervention 1: Acceptance and Commitment Therapy (ACT) has six central processes that lead to psychological flexibility. These six processes are: "Acceptance, Faulting, self as context, present-day c

Eligibility

Sex/Gender

Male

Age

50 Years to 75 Years

Inclusion criteria

Inclusion criteria: Willingness to participate in the research project Age 75 - 50 years Minimum literacy At least one year under treatment (with expert approval) No addiction to any drug Completion of consent to participate in the research Low score of health related quality of life questionnaire and psychological problems scale

Exclusion criteria

Exclusion criteria: Kidney and liver diseases Use of psychoactive drugs

Design outcomes

Primary

Measure	Time frame
Psychological Problem Score on the Short Form of Depression, Anxiety and Stress Scale (DASS 21); Physical and Mental Health Score in Health Related Quality of Life Questionnaire (SF 36). Timepoint: At the beginning of the study (before the intervention) and after 8 sessions of acceptance and commitment group therapy. Method of measurement: The Short Form of Depression, Anxiety and Stress Scale (DASS 21); Health Related Quality of Life Questionnaire (SF 36).	—

Measure

Time frame

Psychological Problem Score on the Short Form of Depression, Anxiety and Stress Scale (DASS 21); Physical and Mental Health Score in Health Related Quality of Life Questionnaire (SF 36). Timepoint: At the beginning of the study (before the intervention) and after 8 sessions of acceptance and commitment group therapy. Method of measurement: The Short Form of Depression, Anxiety and Stress Scale (DASS 21); Health Related Quality of Life Questionnaire (SF 36).

—

Secondary

Measure	Time frame
Health-related quality of life score and psychological problems score. Timepoint: Health-related Quality of Life Questionnaires (SF 36) and Depression, Anxiety and Stress Short Form (DASS 21) at baseline (before intervention) and after treatment protocol. Method of measurement: The Depression, Anxiety and Stress Questionnaire (DASS 21) Health-related quality of life (SF 36).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Baniasadi

Islamic Azad University

f.baniasadi@iaukishint.ac.ir+98 21 4471 9445

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026